Two payment routes need two calculations

The page advertises a starting $99 monthly route with insurance and a $169 cash-pay route. Insurance-related figures depend on the relevant plan and benefit; they are not a universal medication copay. Compounded-plan medication inclusion should not automatically be extended to every branded option. The right question is which exact plan, medicine and recurring charges are being quoted together.

Sources: Found | Weight Loss Medication Personalized for You

Annual savings have commitment terms

Found promotes savings connected with annual prepayment and also displays introductory promotional language. A saving measured against a monthly plan is not the same thing as a flexible monthly cancellation arrangement. Before choosing the annual route, a reader should identify the amount due today, renewal treatment and what happens if the clinician selects a different medication pathway.

Sources: Found | Weight Loss Medication Personalized for You

Program data and drug trials are separate

Found’s page includes results from well-known Wegovy and Zepbound trials with different study durations. Those are evidence about the trial products and populations, not a trial of Found’s compounded plans. A separate program figure describes 1,773 users who reported weight regularly. Regular reporters can differ from everyone who signs up, so that observational group cannot represent a guaranteed enrollee result.

Sources: Found | Weight Loss Medication Personalized for You

Patient stories have a commercial context

The page identifies paid appearances in testimonial material. That does not make every account false, but it does change how a reader should use it. A story can illustrate an experience without establishing how often that experience occurs. The useful comparison is the available clinical process, plan terms and evidence description, rather than treating the most striking story as the usual outcome.

Sources: Found | Weight Loss Medication Personalized for You

Ask about continuity as well as access

An initial consultation is only one part of a prescription relationship. Someone comparing services should understand how to reach the responsible clinician later, which account team handles billing and whether ongoing contact is included. Those questions concern the organization of care; they do not presume a particular treatment schedule or replace the prescriber’s judgment about monitoring and medicine choice.

Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK

Where this review ends

This review was written from official public pages available on October 1, 2026. We did not receive patient care, test medication, inspect a pharmacy or verify a completed purchase. Prices and program descriptions can change. FDA’s warning about unapproved GLP-1 products explains a regulatory distinction; it is not independent validation of this particular provider or product. Individual benefits, risks and eligibility require a qualified clinician.

Sources: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

Official sources

Public-page information checked October 1, 2026. Prices, availability and terms can change. We did not perform patient care or checkout.

  1. Found | Weight Loss Medication Personalized for You ↗Checked 2026-10-01 · official public source
  2. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss ↗Checked 2026-10-01 · official public source
  3. Prescription Medications to Treat Overweight & Obesity - NIDDK ↗Checked 2026-10-01 · official public source